From prevention to precision medicine, researchers aim to translate scientific breakthroughs into better patient outcomes across Europe

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term.

Across the United States, the future of federal funding for cancer research is uncertain. President Donald Trump has proposed cutting the NIH budget by nearly 40% in the 2026 fiscal year.

With an aim to advance cancer research, this Malaysian applied for the British Council's Women in STEM scholarship, and got it!

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have been selected as the next Bowes Biomedical Investigators.

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division. This was supported by lab experiments showing that lowering deuterium levels slowed cell growth, while increasing it accelerated it.

As cancer survival continues to improve globally, attention is increasingly shifting toward survivorship outcomes that extend beyond disease control. Employment has emerged as a contextual factor associated with health-related quality of life,

Roughly 37–40% of all new cancer cases in 2022—about 7.1 million—were linked to preventable causes, suggesting major opportunities for prevention.

This year’s "Brunswick for a Brighter Future" student campaign hopes to surpass last year’s record-breaking effort with a fundraising goal of $125,000 over the seven week competition.